A federal panel of outside experts on Thursday endorsed a coronavirus vaccine from Pfizer and BioNTech, and recommended the Food and Drug Administration (FDA) move forward with emergency authorization.
The panel voted 17-4, with one abstention, that the safety and efficacy of the vaccine outweigh the risks for use in individuals age 16 and older.
The vote is an important step, as the country is poised to start an unprecedented vaccination campaign to stop the COVID-19 pandemic. Continue reading.